This article provides researchers, scientists, and drug development professionals with a comprehensive framework for the functional validation of genetic variants.
This article provides a detailed comparison of CRISPR and RNA interference (RNAi) technologies for genetic perturbation, tailored for researchers, scientists, and drug development professionals.
Low sgRNA efficiency remains a significant bottleneck in CRISPR/Cas9 screens, impacting the signal-to-noise ratio and reliability of genetic screens.
This article provides a comprehensive guide for standardizing CRISPR screening workflows, addressing the critical needs of researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on addressing the pervasive challenge of batch effects in genomic data analysis.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on addressing the pervasive challenge of false positives in scientific screening.
This guide provides researchers, scientists, and drug development professionals with a systematic framework for identifying, troubleshooting, and resolving next-generation sequencing (NGS) data quality issues.
This article provides a comprehensive guide to best practices in functional genomics data analysis, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing functional genomics screening libraries.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing single-guide RNA (sgRNA) for CRISPR-Cas9 genome editing.